Prophylaxis and treatment of venous thromboembolism in patients with cancer: an update.
The close correlation between venous thromboembolism (VTE) and cancer has been known for some time, and numerous reports in the literature have highlighted the epidemiological significance. Moreover, VTE has a substantial impact on morbidity and mortality in oncological patients. The prevention and treatment of VTE are important aspects of the clinical management of patients with cancer. The presence of a tumour is often associated with thrombotic complications that are more difficult to diagnose, and sometimes make the treatment of VTE less effective and more likely to cause haemorrhages.
Falciani
Michela
M
Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Imberti
Davide
D
Prisco
Domenico
D
D000925:Anticoagulants / Q000627:therapeutic use*; D002405:Catheterization, Central Venous / Q000379:methods; D006493:Heparin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D015201:Meta-Analysis as Topic; D009369:Neoplasms / Q000150:complications*; D012307:Risk Factors; D013923:Thromboembolism / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin